Moreover, although most ECM components are produced by stromal fibroblasts and CAFs, MAPK inhibitors can induce production of ECM molecules in melanoma cells, as detected for collagen and FN (Jenkins et al., 2015; Brighton et al., 2018; Diazzi et al., 2020; Girard et al., 2020). This evidence concerns the gene FN1 and melanoma.